WG
MRVI icon

Winton Group’s Maravai LifeSciences MRVI Stock Holding History

Winton Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25,804
Closed -$169K – 779
2023
Q4 		$169K Sell
25,804
-4,185
-14% -$27K 0.01% 659
2023
Q3 		$300K Buy
29,989
+3,279
+12% +$36K 0.02% 552
2023
Q2 		$332K Buy
26,710
+6,599
+33% +$89.1K 0.03% 493
2023
Q1 		$282K Buy
+20,111
New +$289K 0.02% 832
2022
Q1 		– Sell
-11,167
Closed -$468K – 1089
2021
Q4 		$468K Buy
+11,167
New +$452K 0.03% 693

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Winton Group's MRVI Position: Q1 2024 in Review

Winton Group sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 25,804 shares — an estimated $169K sold.

Winton Group first reported a position in MRVI in Q4 2021 and held it in 5 quarters. The position peaked at $468K in Q4 2021. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

  • Winton Group reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Winton Group sold 25,804 Maravai LifeSciences shares in Q1 2024, an estimated $169K.
  • Winton Group first reported a position in Maravai LifeSciences in Q4 2021 and held it in 5 quarters.
  • Winton Group's Maravai LifeSciences position peaked at $468K in Q4 2021.
  • 210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on Winton Group's 13F filing for Q1 2024, filed 14 May 2024.